On the fifth episode of the Psychedelic Invest Podcast, the CEO of Psygen, Danny Motyka joins to talk about manufacturing psychedelics at scale.
During the conversation, host Bruce Eckfedlt asks the hard-hitting questions we all want to know about the development and future accessibility of these medicines.
